ALGN logo

Align Technology, Inc. (ALGN)

Profile

Full Name

Align Technology, Inc.

Ticker

NASDAQ: ALGN

Exchange

NASDAQ

Sector

Healthcare

Industry

Medical Instruments & Supplies

Country

United States

IPO

January 30, 2001

Indexes

S&P 500

Website

http://www.aligntech.com

Employees

21200

Key Details

Price

$205.56(+1.67%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$4.00B(+3.54% YoY)

Annual EPS

$5.62(-3.27% YoY)

PE ratio

37.44

Next earnings date

Jul 30, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $205.56
    ALGN price is $205.56

    30-Day Relative Volume

    0.80
    ALGN 30-day relative volume is 0.80

    Price Performance

    Price Most recent change

    +1.67%
    ALGN price was up +1.67% on Jul 25, 2025

    Price YTD change

    -1.41%
    ALGN price is down -1.41% since January 1st

    Price 1-year change

    -9.06%
    ALGN price is down -9.06% year-on-year

    Price 3-year change

    -18.45%
    ALGN price is down -18.45% over the past 3 years

    Price Range

    Price All-time high

    $737.45
    ALGN price is currently -72.13% below its historical high of $737.45

    Price 3-year low

    $141.74
    ALGN price is currently +45.03% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $14.90B
    ALGN market capitalization is $14.90 billion

    Market cap 3-year change

    -24.27%
    ALGN market capitalization is down -24.27% over the past 3 years

    Market cap All-time high

    $57.76B
    ALGN market capitalization is currently -74.21% below its historical high of $57.76 billion

    Market cap sector rank

    94.56%
    ALGN market capitalization is higher than 94.56% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    -2.96%
    ALGN shares outstanding is down -2.96% year-on-year

    Shares Outstanding 3-Year Change

    -7.14%
    ALGN shares outstanding is down -7.14% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.27
    ALGN beta is 1.27

    200-day SMA

    $198.05
    ALGN price is currently +3.79% above its 200-day simple moving average

    50-day SMA

    $187.36
    ALGN price is currently +9.72% above its 50-day simple moving average

    RSI

    64.01
    ALGN 14-day relative strength index is 64.01

    Volume

    0.80
    ALGN 30-day relative volume is 0.80

    ATR

    $5.85
    ALGN average true range is $5.85

    10-day Historical Volatility

    39.09%
    ALGN 10-day historical volatility is 39.09%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $4.00B
    ALGN annual revenue is $4.00 billion

    Revenue Analysts estimate

    $4.15B
    ALGN annual revenue is currently -3.60% lower than the consensus analysts' forecast

    Revenue 1-year change

    +3.54%
    ALGN annual revenue is up +3.54% year-on-year

    Revenue Sector rank

    90.4%
    ALGN annual revenue is higher than 90.4% of companies in Healthcare sector

    EPS

    EPS

    $5.62
    ALGN annual earnings per share is $5.62

    EPS Analysts estimate

    $10.31
    ALGN annual earnings per share is currently -45.50% lower than the consensus analysts' forecast

    EPS 1-year change

    -3.27%
    ALGN annual earnings per share is down -3.27% year-on-year

    EPS Sector rank

    95.93%
    ALGN annual earnings per share is higher than 95.93% of companies in Healthcare sector

    Profit

    Gross profit

    $2.80B
    ALGN annual gross profit is $2.80 billion

    Gross margin

    70.00%
    ALGN annual gross profit margin is 70.00%

    Operating profit

    $671.76M
    ALGN annual operating income is $671.76 million

    Operating margin

    16.80%
    ALGN annual operating profit margin is 16.80%

    Net income

    $421.36M
    ALGN annual net profit is $421.36 million

    Net margin

    10.54%
    ALGN annual net profit margin is 10.54%

    Expenses

    Total expenses

    $3.33B
    ALGN annual total expenses is $3.33 billion

    Operating expenses

    $2.13B
    ALGN annual total operating expenses is $2.13 billion

    Cost of goods sold

    $1.20B
    ALGN annual cost of goods sold is $1.20 billion

    Selling, general & administrative expenses

    $1.76B
    ALGN annual SGA is $1.76 billion

    Depreciation and amortization

    $145.03M
    ALGN annual depreciation & amortization is $145.03 million

    Interest expense

    -
    ALGN annual interest expense value is unknown

    Income tax

    $187.60M
    ALGN annual income tax is $187.60 million

    EBIT & EBITDA

    EBIT

    $671.76M
    ALGN annual earnings before interest & taxes is $671.76 million

    EBITDA

    $671.76M
    ALGN annual EBITDA is $671.76 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $6.21B
    ALGN annual total assets is $6.21 billion

    Non current assets

    $3.72B
    ALGN annual long term assets is $3.72 billion

    Current assets

    $2.49B
    ALGN annual total current assets is $2.49 billion

    Cash and cash equivalents

    $1.04B
    ALGN annual cash & cash equivalents is $1.04 billion

    Accounts receivable

    $995.68M
    ALGN annual accounts receivable is $995.68 million

    Inventory

    $254.29M
    ALGN annual inventory is $254.29 million

    Liabilities

    Total liabilities

    $2.36B
    ALGN annual total liabilities is $2.36 billion

    Long term liabilities

    $324.59M
    ALGN annual total long term liabilities is $324.59 million

    Current liabilities

    $2.04B
    ALGN annual total current liabilities is $2.04 billion

    Accounts payable

    $108.69M
    ALGN annual accounts payable is $108.69 million

    Debt

    Total debt

    $119.28M
    ALGN annual total debt is $119.28 million

    Total debt 1-year change

    -5.8%
    ALGN annual total debt is down -5.8% year-on-year

    Long term debt

    $88.21M
    ALGN annual long term debt is $88.21 million

    Short term debt

    $31.06M
    ALGN annual short term debt is $31.06 million

    Equity & Capital

    Shareholders equity

    $3.85B
    ALGN annual stockholders equity is $3.85 billion

    Book value

    $3.85B
    ALGN annual book value is $3.85 billion

    Retained earnings

    $2.48B
    ALGN annual retained earnings is $2.48 billion

    Working capital

    $454.41M
    ALGN annual working capital is $454.41 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    $738.23M
    ALGN annual cash flow from operations is $738.23 million

    Cash from operations 1-year change

    -6.05%
    ALGN annual cash flow from operations is down -6.05% year-on-year

    Cash from investing

    -$254.91M
    ALGN annual cash flow from investing activities is -$254.91 million

    Cash from investing 1-year change

    -30.09%
    ALGN annual cash flow from investing activities is down -30.09% year-on-year

    Cash from financing

    -$355.72M
    ALGN annual cash flow from financing activities is -$355.72 million

    Cash from financing 1-year change

    +40.55%
    ALGN annual cash flow from financing activities is up +40.55% year-on-year

    CAPEX

    CAPEX

    $115.58M
    ALGN annual capital expenditures is $115.58 million

    CAPEX 1-year change

    -34.96%
    ALGN annual capital expenditures is down -34.96% year-on-year

    Free Cash Flow

    Free cash flow

    $738.23M
    ALGN annual free cash flow is $738.23 million

    Free cash flow 1-year change

    +21.41%
    ALGN annual free cash flow is up +21.41% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    70.00%
    ALGN annual gross profit margin is 70.00%

    Operating margin

    16.80%
    ALGN annual operating profit margin is 16.80%

    Net margin

    10.54%
    ALGN annual net profit margin is 10.54%

    ROA & ROE

    ROA

    6.85%
    ALGN annual return on assets is 6.85%

    ROE

    11.26%
    ALGN annual return on equity is 11.26%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    37.44
    ALGN price to earnings ratio is 37.44

    PE ratio Sector rank

    69.34%
    ALGN price to earnings ratio is higher than 69.34% of companies in Healthcare sector

    PB Ratio

    PB ratio

    3.93
    ALGN price to book ratio is 3.93

    PB ratio Sector rank

    73.7%
    ALGN price to book ratio is higher than 73.7% of companies in Healthcare sector

    PS Ratio

    PS ratio

    3.74
    ALGN price to sales ratio is 3.74

    PS ratio Sector rank

    54.93%
    ALGN price to sales ratio is higher than 54.93% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $14.15B
    ALGN enterprise value is $14.15 billion

    Enterprise value Sector rank

    93.66%
    ALGN enterprise value is higher than 93.66% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    18.49
    ALGN EV/EBITDA is 18.49

    EV/EBITDA Sector rank

    90.93%
    ALGN EV/EBITDA is higher than 90.93% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    1.22
    ALGN annual current ratio is 1.22

    Quick ratio

    1.10
    ALGN annual quick ratio is 1.10

    Leverage

    Debt to equity

    0.00
    ALGN annual debt to equity ratio is 0.00

    Interest coverage ratio

    -
    ALGN annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    7
    ALGN piotroski f-score is 7

    Altman Z-Score

    5.43
    ALGN altman z-score is 5.43

    Analyst ratings

    Recent major analysts updates

    Jul 9, 25 Evercore ISI Group
    Outperform
    May 1, 25 Wells Fargo
    Overweight
    May 1, 25 Piper Sandler
    Overweight
    May 1, 25 Needham
    Hold
    May 1, 25 Evercore ISI Group
    Outperform
    Apr 29, 25 Mizuho
    Outperform
    Apr 25, 25 HSBC
    Hold
    Apr 24, 25 UBS
    Neutral
    Apr 15, 25 Morgan Stanley
    Overweight
    Mar 25, 25 Mizuho
    Outperform

    Institutional Ownership

    Screeners with ALGN included

    US stocks
    High Piotroski score stocks
    S&P 500 companies earnings calendar
    Stocks with high beta
    Most recommended stocks
    Best performing stocks last 3 months
    NASDAQ Dividend Calendar
    Stocks above SMA 50
    S&P 500 companies
    Stocks below analysts price target
    • What is the ticker symbol for Align Technology, Inc.?
    • Does Align Technology, Inc. pay dividends?
    • What sector is Align Technology, Inc. in?
    • What industry is Align Technology, Inc. in?
    • What country is Align Technology, Inc. based in?
    • When did Align Technology, Inc. go public?
    • Is Align Technology, Inc. in the S&P 500?
    • Is Align Technology, Inc. in the NASDAQ 100?
    • Is Align Technology, Inc. in the Dow Jones?
    • When was Align Technology, Inc.'s last earnings report?
    • When does Align Technology, Inc. report earnings?

    What is the ticker symbol for Align Technology, Inc.?

    The ticker symbol for Align Technology, Inc. is NASDAQ:ALGN

    Does Align Technology, Inc. pay dividends?

    No, Align Technology, Inc. does not pay dividends

    What sector is Align Technology, Inc. in?

    Align Technology, Inc. is in the Healthcare sector

    What industry is Align Technology, Inc. in?

    Align Technology, Inc. is in the Medical Instruments & Supplies industry

    What country is Align Technology, Inc. based in?

    Align Technology, Inc. is headquartered in United States

    When did Align Technology, Inc. go public?

    Align Technology, Inc.'s initial public offering (IPO) was on January 30, 2001

    Is Align Technology, Inc. in the S&P 500?

    Yes, Align Technology, Inc. is included in the S&P 500 index

    Is Align Technology, Inc. in the NASDAQ 100?

    No, Align Technology, Inc. is not included in the NASDAQ 100 index

    Is Align Technology, Inc. in the Dow Jones?

    No, Align Technology, Inc. is not included in the Dow Jones index

    When was Align Technology, Inc.'s last earnings report?

    Align Technology, Inc.'s most recent earnings report was on April 30, 2025

    When does Align Technology, Inc. report earnings?

    The next expected earnings date for Align Technology, Inc. is July 30, 2025
    On this page